Image Image Image Image Image Image Image Image Image Image
Access
Up

Up

AG_assaigCHROMA

· 29/01/2015

CHROMA: Clinical Trial of Lampalizumab for Geographic Atrophy Secondary to Age-Related Macular Degeneration

Injeccions

· 19/12/2014

FOVISTA NR: Clinical Trial for neovascular age-related macular degeneration

Lite 1

· 21/12/2014

LITE: Development of Advanced Laser Imaging Techniques for the anterior and posterior Eye

Foto2

· 01/01/2015

FOVISTA: Clinical Trial for subfoveal neovascular age-related macular degeneration

DMAE atrofica

· 19/03/2014

Clinical trial in antiretroviral-naive patients with choroidal neovascularization secondary to AMD

Foto4_def

· 31/03/2014

Phase III Study of Lampalizumab in patients with geographic atrophy secondary to AMD

Foto44_3

· 20/12/2014

MPL4 GA: A phase I study in subjects with geographic atrophy secondary to dry age-related macular degeneration  

Foto49_3

· 20/12/2014

Oral Omega 3 GA. A phase II in subjects with geographic atrophy secondary to AMD

Queratitis

· 02/07/2014

Clinical Trial M-13-027: Evaluation of Clinical Outcomes Following Treatment with Systane® Balance in Dry Eye Subjects with Lipid Deficiency

Glaucoma_Nervioptic1_PORTADA

· 02/07/2014

Prospective, randomised, placebo-controlled, double-masked, three-armed, multicenter Phase II/III trial to establish the safety and efficacy of a topical treatment of Neovascular Glaucoma

Traccio macular

· 02/07/2014

JETREA M-13-056 Assessment of anatomical and functional outcomes in patients treated with ocriplasmin for vitreomacular traction/symptomatic vitreomacular adhesion

Foto3

· 19/03/2014

TREND: A phase IIIb, randomized, a 12-month, Visual Acuity assessor-masked, interventional study assessing the efficacy and safety of the Treat and Extend vs monthly regimens of 0.5 mg ranibizumab in patients with newly diagnosed nAMD

Foto1_def2

· 19/03/2014

MACBETH. Phase IV Study to evaluate the efficacy of aflibercept in subjects with neovascular Age-related Macular Degeneration (wAMD), without optimal response to repeated monthly intravitreal injections of Anti Vascular Endothelial Growth Factor (Anti VEGF-A) Therapy

Foto51_2

· 26/03/2013

GAIN. Characterization of geographic atrophy progression in patients with age-related macular degeneration: evolution and risk factors associated with geographic atrophy progression

Foto49_3

· 26/03/2013

Oral Omega 3 Drusen: A phase II randomized, double-mask study to establish the safety and efficacy of High-Dose Oral Omega 3 in subjects with high-risk drusen secondary to dry age-related macular degeneration 

Last modified: 29 November, 2021 - 13:07